For millions of women, menopause is not simply a hormonal event — it may be a biological inflection point that reshapes the pace of aging itself. Understanding which biomarkers best capture this acceleration matters enormously for personalizing care and identifying women at elevated risk for cardiovascular disease, cognitive decline, and skeletal fragility decades before clinical symptoms emerge.
This review, published in JOGNN, maps the mechanistic pathways through which menopause may amplify biological aging: estrogen withdrawal disrupts antioxidant defenses and promotes chronic low-grade inflammation; body composition shifts toward visceral adiposity accelerate metabolic dysregulation; and epigenetic reprogramming — measurable via DNA methylation clocks such as GrimAge and PhenoAge — may register a biological age that diverges meaningfully from chronological age. The author highlights composite phenotypic age indices alongside molecular epigenetic clocks as the most promising quantitative tools, while noting that tissue-specificity and outcome-specificity limit cross-study comparability. Crucially, no single biomarker has yet achieved a validated clinical threshold sufficient to guide routine menopause management.
This review sits within a rapidly maturing field. Second- and third-generation epigenetic clocks have demonstrated stronger associations with morbidity and mortality than chronological age in several large prospective cohorts, yet almost all pivotal clock-validation studies were conducted in mixed-sex or predominantly male samples. The postmenopausal window represents a genuinely understudied stress-test for these tools. The author's call for longitudinal, diverse perimenopause cohorts is well-placed — cross-sectional data cannot resolve whether accelerated clock aging precedes or merely correlates with adverse outcomes. For clinicians and researchers alike, the field's most pressing gap is not more biomarkers but rather intervention trials that test whether lifestyle or hormonal strategies can reverse clock-measured aging in this population. This review is incremental but a useful synthesis of a fragmented literature.
